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During our studies of bovine brain neutral glycosphingolipids (Ngsl’s), WC have purilied a compound that co-migrates on thin-layer chromatogram 
with standard GAI (purified by acid hydrolysis ol’GM 1) and close to penta- (nLc,Ccr) glycosylccramide from bovine erythrocytea. The structure 
of the purified Ngsl from brain has been established by pcrmethylation a d by stepwise xoglycosidase hydrolysis. 600 MHz ItI NMR spectroscopy 
of the oligosaccharide obtained from the Ngsl arter endoglycoceramidasc hydrolysis confirms the structure as ganglio&tetraosylceramide 
(GgOse,Cer or GAl) as Gal~l~3GalNA~1~JGal~l~4Gl~l~lCer. We have identified GAI in bovine, rat and human brain and myelin by 
TLC-immunostaining with monospecific anti-GA1 antiserum. 
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1 a INTRODUCTION 
The majority of the brain gangliosides are of the gan- 
glio-series, with GM4, GM3, GD3 and neolacto-series 
compounds minor constituents. The gangliosides GM 1, 
GDla, GDlb, GTl and GQl contain ganglio-N- 
tetraosylceramide (asialo GM1 or GAl) as the neutral 
glycolipid core structure. Appreciable amounts of the 
globe- (Gb,Cer), ganglio- (Gg,Cer) and neolacto-series 
glycolipids have been characterized in normal human 
fetal brain [l]. II13Fuc-nLc,Cer, a minor constituent of 
normal human brain [2] has been reported in an appre- 
ciable amount (10%) in normal fetal brain [l] and is 
considered a stage-specific antigen. Mouse NK cells 
contain a high concentration of GA1 [3] that has been 
shown to be a precursor for GM I b synthesis [4,5]. The 
immunological and chemical identification of GA1 in 
mouse myelin [6] and characterization of GM 1 b in nor- 
mal human brain [7] led us to purify and characterize 
GA1 in mammalian brain. The present study describes 
the purification and characterization of GA1 in bovine 
Abbreuiarions: TLC, thin-layer chromatography; Ngsl, neutral glyco- 
sphingolipid; GMI, IIsNcuAcGgOse,Cer; GMlb, lVJNeuAcGg- 
OsedCer; GA1 or GgOse,Cer, 1113~alGglCer; Gb,Ccr, Galal- 
Gs@l--4GlcCer: Gg,Cer, GalNAcfii*4Gal~I+lGIcCer; LacCer, 
Ga~l+IGlcCcr; nLqCer, Ga~l-b3Gl~NA~~Gal~l~GlcCer; 
nLc,Cer. IV’GalnLc,Cer. Gangliosides are designated following Sven- 
nerholm, L. (1963) J. Neurochem. 10,613-623. 
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brain and its immunochemical identification i  rat and 
human brain and CNS myelin. 
2. MATERIALS AND METHODS 
Bovine brain was collected at a local abattoir, human brain was 
obtained immediately after autopsy following the accidental death of 
a previously healthy man, and rat brain was obtained from our labo. 
ralory after decapitation. Materials and methods were those prcvi- 
ously used in our laboratory [S]. 
Glycolipids were extracted and Ngsl’s were separated from gangli- 
osidcs by DEAE-Sephadcx A50 (acetate rorm). Individual Ngl’s were 
purified through biosil A (Bio-Rad) columns using chloro- 
form:methanol:water and chloroform:mcthanol:2.5 N ammonia sol- 
vent syslems, and collected in fractions that were checked by tic. The 
purified fractions were pooled, and the purity of the compound was 
determined by tic using two dhTcrent solvent systems. Approximately 
300 pg of the purified Ngsl was permcthylated and acetylatcd [9.10] 
and the partially mcthylated alditol acetates were analyzed on a DB-1 
column on a Kcwlctt-Packard 5980 chromatograph-man speclromc- 
ter. The Tatty acids and long-chain bases were analyzed as methyl ester 
and trimethyisilyl derivatives. Sequential carbohydrate r sidues WCIX 
determined by specific exoglycosidase (200 nilunit) digestion of the 
Ngsl(20& in 50 mM citrate buffer (pH 4.2) conraining 0.1% tauro- 
cholate, 
For NMR spectroxopy. Ihc Ngsl was cleaved by endodycocerarni- 
dase (3 m unit) in 50 mM acetate buffer (pH 6.0) containing 0.05% 
sodium taurocholatc. The reaction was terminated by the addition of 
chloroform:methanol 2: 1 (v/v) agd the free oligosaccharide was puri- 
fied from the upper phase through a biogel P2 column eluling with 
distilled water [I I], Both the Ngsl and the oligosaccharide released 
from the Ngsl by endoglycoceramidasc were analyzed by ‘H NMR 
spectroscopy at 600 MHz. Approximately 300 pug af’the glycosphin- 
golipid sample [121 and 250 pg of the oligosaccharide sample [8,13] 
were prepared for NMR analysis. 600 MHz ‘H NMR spectroscopy 
was pert’ormed on a Broker AMX-600 spectrometer iutrrfacrj with 
an Aspect X32 computer. The probe temperature was kept at 23’C. 
Further experimental details are essentially as described [13]. Chemi- 
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Fig. 1. Thin iayer chromatogram of the purified glycosphingolipid from bovine brain. The plates were developed in (a) chloroform:methanol:2,5 
N ammonia (60:40:9 WV) and (b) chloroform:methanol:water (60:40:9 v/v) and visualized after DPA-spray. (Lane I) standard GA1 (GgOse,Cer); 
(lane 2) purified glycosphingolipid; (lane 3) standard neutral glycosphingolipid mixture from baroine rythrocyles. 
GlcCer 
cal shifts (S, for the glycolipid are expressed in ppm downfield from 
TM.5 measured by reference to internal DMSO-d5 at 6 2.490; those 
for the oligosaccharide are expressed inppm downfield from internal 
sodium 4,4-dimethyl&silapcntanc-I-sulfonate, m asured by refer- 
ence to internal acetate (6 1.908 in D,O at 23°C) with an accuracy of 
0.002 ppm. 
a a 
LacCsr 
Myelin was prepared according to Norton and Poduslo [14] by 
repeated sucrose (On32 M and 0.8 M) density gradient centrifugation 
and washing of the interph:a:e with distilled water. The glycolipid was 
extracted and the purified Ngsl’s were acetylated (pyridine:acetic an- 
# 
hydride, 3:2) and resolved on a florisil column [IS] with dichlor- 
GbgCer oethane:acetonc (I:1 v/v). The acetylated Ngsl’s were dialyzed and 
lyophilizcd slier deacetylation with sodium methoxide. TtC-im- 
munostaining was performed according to Kusunoki et al. [6] using 
nLc Cer 
4 
1% BSA in PBS, goat anti-rabbit IgG peroxidase(secondary ntibody) 
and monospecific an&GA1 antisera (primary antibody) prepared by 
-a * 
nLc5Ckr 
absorption of anti-GAl-IgG on asialo-GMI-coated latex beads and 
eking wilh 1 M NaSCN [16.17]. 
1 
> aj_ .i _.j s 
Fig. 2. Stepwise specitic exoglycasidase hydrolysis of the purified 
glycolipid. The plate was developed in chloroform:mcthanol:water 
(GO:499 v/v) and visualized after DPA-spray. (Lane 1) standard 
GgOse,Cer; (lane 2) purified glycolipid; (lane 3) lane 2 + /3-galactosi- 
dase: (lane 4) lane 3 + P-hcxosaminidase; (lane 5) lane 4 + B-galac- 
tosidase; (lane 6) standard neutral glycolipid mixture. 
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Fig. 3, ‘H NMR speclrum of the oligosuccharidc from Ngsl (600 MHz. ?3T. DIO), (Upper panel) overall ‘H NMR spectrum, (Lower panel) 
expanded regions showing the anomeric and non-anomrric structural reporter group signals indicalivc of the structure: 
GaI~(l-3)GalNA~(I~4)Gal~(l~4)Glc. Superscripts are used in Gal” and Gal” to difl’ercnktte between the Gal@(l-3) and Gai,&l-I) residues, 
respectively. 
3. RESULTS AND DISCUSSION 
The Ngsl (yield approximately 1mg/40 g of acetone- 
dried brain) was homogeneous by TLC with two differ- 
ent solvent systems (Fig. 1). Its compositional analysis 
indicated Gal:GalNAc:Glc in a molar ratio of 
1.95:0.8:1.0 and sphingenine (Cl&l) as the only base. 
The acyl groups were mainly stearic with lesser amounts 
of palmitic and oleic acids (Cl&O 86,5%; Cl6:O 8.0%; 
Cl& 1 5.5%). The four peaks of the partially methylated 
hexitol acetate derivatives were identified by GC-MS 
as 2,3,4,6-tetra-O-methylgalactitol-l,S-diacetates, 2,3,6- 
tri-C?-methylgalactitol-1,4,5_triacetates, 2,3,6-t&0- 
methylglucitol-1,4,5-triacetates nd 4,6-di-0methyl-2- 
deoxy-2-_‘V-methylacetarnidogalactitol- 1,3,5-triacetates. 
The parent glycolipid was hydrolyscd by @-galactosi- 
dase (and not by a-galactosidase orP-hexosaminidase) 
to a trihexaosylceramide that migrated close to the RF 
of standard Gb,Cer. The product was hydrolysed fur- 
ther to di- and monohcxaosylceramide by /3-hexosam- 
inidase and p-galactosidase (Fig. 2). 600 MHz NMR 
spectroscopy of the oligosaccharide (Fig. 3) confirmed 
the structure of the Ngsl as GgGse,Cer (GA1 or asialo- 
GMl). The ‘H NMR spectrum (Fig. 3) of the oligosac- 
charide released from the Ngsl showed the presence uf 
a tetrasaccharide with the structure: 
Galj( 1-+3)GalNA@(I~4)Ga&?( l-4)Glc 
The chemical shifts of the structural reporter groups 
(marked in Fig. 3: H 1 of Gal3 at S 4.448; H 1 of GalNAc 
at S4.706/4.701; Hl of GAIJ at 4.443/4&l; Hl of Glca 
at 5.219; Hl of Glcp at 4.665) are virtually identical to 
those reported [16] for GgGsea t SO0 MHz and 27OC. 
600 MHz ‘H NMR spectroscopic analysis of tbc in*mct 
Ngsl in DMSO-d6 confirmed this structure; the chemi- 
cal shifts of the structural reporter groups are essentially 
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Fig, 4, Thin-layer chromatography stainiug of the Ngsl’s from brain 
and myelin. The plate was developed in chloroform:methanol:watcr 
(60:40:9 v/v) and immuno-stained with antiGAl antisera. (Lane I) 
bovine brain; (lane 2) normal human brain; (lane 3) rat brain; (lane 
4) standnrd GgOSe,Cer; (lane 5) bovine myelin; (lane 6) human mye- 
lia; (lane 7) rat myelin. 
the same as those reported for GAI by Koernar et al. 
[lo] (compound 5. analyzed at 500 MHz, 3OOC). Glyco- 
lipids of the globe-series are the major class in visceral 
organs, while fucolipids of the lacto- and neolacto-series 
are abundant in the ephithelial tissues of the digestive 
tract, Although the major glycolipids of normal adult 
brain consists of galactosylceramide, sulfatide, and gan- 
gliosides of the ganglio-series [l], the accumulation of
some neutral glycolioids of the ganglio-, globo- and ne- 
olacto-series in brains from patients with inherited 
sphingolipidoses cannot be explained directly by the 
relevant glycosidase deficiencies (e.g. /3-N-acetylhex- 
osaminidase in GM2 gangliosidosis, p-galactosidase in
GM1 gangliosidosis and galactosylceramide-p-galacto- 
sidase in Krabbe’s disease). Gangliotetraosylceramide 
is one of the main glycolipids accumulating in GM1 
gangliosidosis brain [ 171, but is barely detectable in nor- 
mal brain [3]. It has also been reported in a few studies 
of juvenile [18,19] and fetal human brain [I] (identified 
by TLC and hexaosyi molar composition). 
GA1 has been identified in adult mouse myelin by 
immunohistochemical staining, although its occurrence 
in other subcellular brain fractions was not excluded. 
The molar composition was that of GA1 [6], br.tt a de- 
tailed chemical analysis was not done. 
We have purified and analytically characterized GA1 
from bovine brain and identified it in adult rat and 
normal human brain and in CNS myelin (Fig. 4). As 
shown in Fig. 4 two immunoreactive bands could be 
observed, particularly in rat brain. These bands were 
separated, purified by column chromatography and 
chemically characterized. Both of them are GA1 species 
with the same oligosaccharide but a different fatty acid 
composition. 
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It is noteworthy that experimental autoimmune en- 
ccphalomyelitis can be induced in guinea pigs by GA1 
[22] suggesting a possible role of GA1 in demyelination. 
Though its importance in myelination and demyelina- 
tion is unknown, the careful study of the topographical 
distribution of GA1 during normal brain development 
may clarify its iriirolvement in myelinogenesis. 
To our knowledge, this is the first report of analytical 
characterization of GA1 and its presence on adult nor- 
mal human meyiin. 
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